M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib et al., Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era, Circulation, vol.122, pp.156-163, 2010.

N. F. Voelkel, J. Gomez-arroyo, A. Abbate, H. J. Bogaard, and M. R. Nicolls, Pathobiology of pulmonary arterial hypertension and right ventricular failure, The European respiratory journal, vol.40, pp.1555-1565, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-02612634

A. Huertas, F. Perros, L. Tu, S. Cohen-kaminsky, D. Montani et al., Immune dysregulation and endothelial dysfunction in pulmonary arterial hypertension: a complex interplay, Circulation, vol.129, pp.1332-1340, 2014.

L. Leng, C. N. Metz, Y. Fang, J. Xu, S. Donnelly et al., MIF signal transduction initiated by binding to CD74, The Journal of experimental medicine, vol.197, pp.1467-1476, 2003.

S. Tillmann, J. Bernhagen, and H. Noels, Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis, Frontiers in immunology, vol.4, p.115, 2013.

J. L. Gregory, E. F. Morand, S. J. Mckeown, J. A. Ralph, P. Hall et al., Macrophage migration inhibitory factor induces macrophage recruitment via CC chemokine ligand 2, J Immunol, vol.177, pp.8072-8079, 2006.

H. Fan, P. Hall, L. L. Santos, J. L. Gregory, G. Fingerle-rowson et al., Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase, J Immunol, vol.186, pp.4915-4924, 2011.

E. J. Miller, J. Li, L. Leng, C. Mcdonald, T. Atsumi et al., Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart, Nature, vol.451, pp.578-582, 2008.

J. Bernhagen, R. Krohn, H. Lue, J. L. Gregory, A. Zernecke et al., MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment, Nature medicine, vol.13, pp.587-596, 2007.

R. Damico, T. Simms, B. S. Kim, Z. Tekeste, H. Amankwan et al., p53 mediates cigarette smoke-induced apoptosis of pulmonary endothelial cells: inhibitory effects of macrophage migration inhibitor factor, American journal of respiratory cell and molecular biology, vol.44, pp.323-332, 2011.

H. Lue, M. Thiele, J. Franz, E. Dahl, S. Speckgens et al., Macrophage migration inhibitory factor (MIF) promotes cell survival by activation of the Akt pathway and role for CSN5/JAB1 in the control of autocrine MIF activity, Oncogene, vol.26, pp.5046-5059, 2007.

K. Takahashi, K. Koga, H. M. Linge, Y. Zhang, X. Lin et al., Macrophage CD74 contributes to MIF-induced pulmonary inflammation, Respiratory research, vol.10, p.33, 2009.

Y. Gore, D. Starlets, N. Maharshak, S. Becker-herman, U. Kaneyuki et al., Macrophage migration inhibitory factor induces B cell survival by activation of a CD74-CD44 receptor complex, The Journal of biological chemistry, vol.283, pp.2784-2792, 2008.

F. S. De-man, L. Tu, M. L. Handoko, S. Rain, G. Ruiter et al.,

, American journal of respiratory and critical care medicine, vol.186, pp.780-789, 2012.

C. Guignabert, L. Tu, M. Izikki, L. Dewachter, P. Zadigue et al., Dichloroacetate treatment partially regresses established pulmonary hypertension in mice with SM22alpha-targeted overexpression of the serotonin 22
URL : https://hal.archives-ouvertes.fr/inserm-00499630

, FASEB journal : official publication of the Federation of American Societies for Experimental Biology, vol.23, pp.4135-4147, 2009.

A. Huertas, L. Tu, N. Gambaryan, B. Girerd, F. Perros et al., Leptin and regulatory Tlymphocytes in idiopathic pulmonary arterial hypertension, The European respiratory journal, vol.40, pp.895-904, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00913076

N. Ricard, L. Tu, L. Hiress, M. Huertas, A. Phan et al., Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension, Circulation, vol.129, pp.1586-1597, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02578269

L. Tu, F. S. De-man, B. Girerd, A. Huertas, M. C. Chaumais et al., A critical role for p130Cas in the progression of pulmonary hypertension in humans and rodents, American journal of respiratory and critical care medicine, vol.186, pp.666-676, 2012.
URL : https://hal.archives-ouvertes.fr/inserm-00905191

L. Tu, L. Dewachter, B. Gore, E. Fadel, P. Dartevelle et al., Autocrine fibroblast growth factor-2 signaling contributes to altered endothelial phenotype in pulmonary hypertension, American journal of respiratory cell and molecular biology, vol.45, pp.311-322, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00579959

I. Binsky, M. Haran, D. Starlets, Y. Gore, F. Lantner et al., IL-8 secreted in a macrophage migrationinhibitory factor-and CD74-dependent manner regulates B cell chronic lymphocytic leukemia survival, Proceedings of the National Academy of Sciences of the United States of America, vol.104, pp.13408-13413, 2007.

C. Guignabert, B. Raffestin, R. Benferhat, W. Raoul, P. Zadigue et al.,

, monocrotaline-induced pulmonary hypertension in rats, Circulation, vol.111, pp.2812-2819, 2005.

N. El-bizri, C. Guignabert, L. Wang, A. Cheng, K. Stankunas et al., SM22alpha-targeted deletion of bone morphogenetic protein receptor 1A in mice impairs cardiac and vascular development, and influences organogenesis, Development, vol.135, pp.2981-2991, 2008.

C. Guignabert, C. M. Alvira, T. P. Alastalo, H. Sawada, G. Hansmann et al., Tie2-mediated loss of peroxisome proliferator-activated receptor-gamma in mice causes PDGF receptor-beta-dependent pulmonary arterial muscularization, American journal of physiology Lung cellular and molecular physiology, vol.297, pp.1082-1090, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00499633

S. Badve, C. Deshpande, Z. Hua, and L. Logdberg, Expression of invariant chain (CD 74) and major histocompatibility complex (MHC) class II antigens in the human fetus. The journal of histochemistry and cytochemistry : official journal of the, Histochemistry Society, vol.50, pp.473-482, 2002.

M. Pyrz, B. Wang, M. Wabl, and F. S. Pedersen, A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoform, Molecular cancer, vol.9, p.86, 2010.

V. Richard, N. Kindt, C. Decaestecker, H. J. Gabius, G. Laurent et al., Involvement of macrophage migration inhibitory factor and its receptor (CD74) in human breast cancer, Oncology reports, vol.32, pp.523-529, 2014.

E. E. Eriksson, Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects, Current opinion in lipidology, vol.15, pp.553-558, 2004.

B. B. Davis, Y. H. Shen, D. J. Tancredi, V. Flores, R. P. Davis et al., Leukocytes are recruited through the bronchial circulation to the lung in a spontaneously hypertensive rat model of COPD, PloS one, vol.7, p.33304, 2012.

E. Stacher, B. B. Graham, J. M. Hunt, A. Gandjeva, S. D. Groshong et al., Modern age pathology of pulmonary arterial hypertension, American journal of respiratory and critical care medicine, vol.186, pp.261-272, 2012.

P. L. Vera, X. Wang, R. J. Bucala, and K. L. Meyer-siegler, Intraluminal blockade of cell-surface CD74 and glucose regulated protein 78 prevents substance P-induced bladder inflammatory changes in the rat, PloS one, vol.4, p.5835, 2009.

J. L. Cracowski, F. Chabot, J. Labarere, P. Faure, B. Degano et al., Proinflammatory cytokine levels are linked with death in pulmonary arterial hypertension. The European respiratory journal, 2013.

E. Soon, A. M. Holmes, C. M. Treacy, N. J. Doughty, L. Southgate et al., Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension, Circulation, vol.122, pp.920-927, 2010.

M. Rabinovitch, C. Guignabert, M. Humbert, and M. R. Nicolls, Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension, Circulation research, vol.115, pp.165-175, 2014.

G. P. Sorescu, M. Sykes, D. Weiss, M. O. Platt, A. Saha et al., Bone morphogenic protein 4 produced in endothelial cells by oscillatory shear stress stimulates an inflammatory response, The Journal of biological chemistry, vol.278, pp.31128-31135, 2003.

A. Csiszar, M. Ahmad, K. E. Smith, N. Labinskyy, Q. Gao et al., Bone morphogenetic protein-2 induces proinflammatory endothelial phenotype, The American journal of pathology, vol.168, pp.629-638, 2006.

R. J. Davies, A. M. Holmes, J. Deighton, L. Long, X. Yang et al., BMP type II receptor deficiency confers resistance to growth inhibition by TGF-beta in pulmonary artery smooth muscle cells: role of proinflammatory cytokines, American journal of physiology Lung cellular and molecular physiology, vol.302, pp.604-615, 2012.

T. Helbing, R. Rothweiler, E. Ketterer, L. Goetz, J. Heinke et al., BMP activity controlled by BMPER regulates the proinflammatory phenotype of endothelium, Blood, vol.118, pp.5040-5049, 2011.

B. Zhang, M. Shen, M. Xu, L. L. Liu, Y. Luo et al., Role of macrophage migration inhibitory factor in the proliferation of smooth muscle cell in pulmonary hypertension, Mediators of inflammation, p.840737, 2012.

Y. Zhang, A. Talwar, D. Tsang, A. Bruchfeld, A. Sadoughi et al., Macrophage migration inhibitory factor mediates hypoxiainduced pulmonary hypertension, Mol Med, vol.18, pp.215-223, 2012.

N. Gambaryan, F. Perros, D. Montani, S. Cohen-kaminsky, M. Mazmanian et al., Targeting of c-kit+ haematopoietic progenitor cells prevents hypoxic pulmonary hypertension, The European respiratory journal, vol.37, pp.1392-1399, 2011.

K. Koga, A. Kenessey, and K. Ojamaa, Macrophage migration inhibitory factor antagonizes pressure overload-induced cardiac hypertrophy, American journal of physiology Heart and circulatory physiology, vol.304, pp.282-293, 2013.

A. Schober, J. Bernhagen, M. Thiele, U. Zeiffer, S. Knarren et al., Stabilization of atherosclerotic plaques by blockade of macrophage migration inhibitory factor after vascular injury in apolipoprotein E-deficient mice, Circulation, vol.109, pp.380-385, 2004.